Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ · Healthcare
Lexicon Pharmaceuticals, Inc. Long Term Debt 2009–2025
Lexicon Pharmaceuticals, Inc. annual long term debt history from 2010 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Lexicon Pharmaceuticals, Inc. long term debt as of December 31, 2025: 49.4M, a 50.74% decrease year-over-year.
- Lexicon Pharmaceuticals, Inc. long term debt for 2025 were 49.4M, a 50.74% decrease from 2024.
- Lexicon Pharmaceuticals, Inc. long term debt for 2024 were 100.3M, a 0.79% increase from 2023.
- Lexicon Pharmaceuticals, Inc. long term debt for 2023 were 99.5M, a 104.75% increase from 2022.
- Lexicon Pharmaceuticals, Inc. long term debt for 2022 were 48.6M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Lexicon Pharmaceuticals, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $49 |
| 2024 | $100 |
| 2023 | $100 |
| 2022 | $49 |
| 2019 | $249 |
| 2018 | $250 |
| 2017 | $252 |
| 2016 | $101 |
| 2015 | $106 |
| 2014 | $108 |
| 2013 | $22 |
| 2012 | $23 |
| 2011 | $23 |
| 2010 | $27 |
Lexicon Pharmaceuticals, Inc. Long Term Debt — FAQ
Lexicon Pharmaceuticals, Inc. (LXRX) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LXRX's long term debt history?
The chart and table above show Lexicon Pharmaceuticals, Inc.'s long term debt by year and by quarter, including the growth rate.